Genocea OTC Stock Today

Genocea Biosciences is selling for under 0.0123 as of the 28th of January 2022; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.0123. Equity ratings for Genocea Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of February 2020 and ending today, the 28th of January 2022. Click here to learn more.

Genocea Biosciences OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Genocea Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Genocea Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Genocea Biosciences is not yet fully synchronised with the market data
Genocea Biosciences has some characteristics of a very speculative penny stock
Legal NameGenocea Biosciences
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Genocea Biosciences' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
Genocea Biosciences [GGNNW] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with current market capitalization of 5.72 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genocea Biosciences's market, we take the total number of its shares issued and multiply it by Genocea Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.
Check Genocea Biosciences Probability Of Bankruptcy

Genocea Stock Price Odds Analysis

What are Genocea Biosciences' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Genocea Biosciences jumping above the current price in 90 days from now is about 77.07%. The Genocea Biosciences probability density function shows the probability of Genocea Biosciences otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon the otc stock has a beta coefficient of 96.5396. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Genocea Biosciences will likely underperform. In addition to that, the company has an alpha of 1583.1242, implying that it can generate a 1583.12 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 0.0123HorizonTargetOdds Up 0.0123 
22.89%90 days
 0.0123 
77.07%
Based on a normal probability distribution, the odds of Genocea Biosciences to move above the current price in 90 days from now is about 77.07 (This Genocea Biosciences probability density function shows the probability of Genocea OTC Stock to fall within a particular range of prices over 90 days) .

Genocea Biosciences Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Genocea Biosciences market risk premium is the additional return an investor will receive from holding Genocea Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Genocea Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Genocea Biosciences' alpha and beta are two of the key measurements used to evaluate Genocea Biosciences' performance over the market, the standard measures of volatility play an important role as well.

Genocea Stock Against Markets

Picking the right benchmark for Genocea Biosciences otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Genocea Biosciences otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Genocea Biosciences is critical whether you are bullish or bearish towards Genocea Biosciences at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genocea Biosciences otc stock to make a market-neutral strategy. Peer analysis of Genocea Biosciences could also be used in its relative valuation, which is a method of valuing Genocea Biosciences by comparing valuation metrics with similar companies.
Please check Risk vs Return Analysis. Note that the Genocea Biosciences information on this page should be used as a complementary analysis to other Genocea Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Genocea OTC Stock analysis

When running Genocea Biosciences price analysis, check to measure Genocea Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genocea Biosciences is operating at the current time. Most of Genocea Biosciences' value examination focuses on studying past and present price action to predict the probability of Genocea Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Genocea Biosciences' price. Additionally, you may evaluate how the addition of Genocea Biosciences to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Genocea Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genocea Biosciences. If investors know Genocea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genocea Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Genocea Biosciences is measured differently than its book value, which is the value of Genocea that is recorded on the company's balance sheet. Investors also form their own opinion of Genocea Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Genocea Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genocea Biosciences' market value can be influenced by many factors that don't directly affect Genocea Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genocea Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Genocea Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genocea Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.